PRESS RELEASE published on 01/29/2024 at 01:03, 9 months 24 days ago ROSEN, A TOP RANKED LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important February 9 Deadline in Securities Class Action - EGRX Rosen Law Firm, a global investor rights law firm, reminds Eagle Pharmaceuticals, Inc. investors of February 9, 2024 lead plaintiff deadline in securities class action. The lawsuit claims investors suffered damages due to false and misleading statements Rosen Law Firm Securities Class Action Investor Rights Misleading Statements Eagle Pharmaceuticals Inc.
PRESS RELEASE published on 01/29/2024 at 00:05, 9 months 24 days ago ROSEN, A LONGSTANDING LAW FIRM, Encourages EHang Holdings Limited Investors to Secure Counsel Before Important February 2 Deadline in Securities Class Action First Filed by the Firm - EH Rosen Law Firm encourages EHang Holdings Limited investors to secure counsel before important February 2 deadline in securities class action. Investors may be entitled to compensation. Details of the case include misleading statements about business operations and prospects Rosen Law Firm Securities Class Action EHang Holdings Limited Investment Fraud Business Litigation
PRESS RELEASE published on 01/28/2024 at 18:03, 9 months 24 days ago ROSEN, A LEADING LAW FIRM, Encourages Assertio Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ASRT Rosen Law Firm encourages Assertio Holdings, Inc. investors to secure counsel before important deadline in securities class action. Investors may be entitled to compensation. Details of the case include misleading statements and unsustainable reliance on pharmaceutical products Rosen Law Firm Securities Class Action Compensation Assertio Holdings Inc Misleading Statements
PRESS RELEASE published on 01/28/2024 at 17:37, 9 months 24 days ago ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Inspired Entertainment, Inc. Investors to Inquire About Securities Class Action Investigation - INSE The Rosen Law Firm, P.A., a globally respected law firm, continues to investigate potential securities claims on behalf of shareholders of Inspired Entertainment, Inc. (NASDAQ: INSE) resulting from allegations that the company may have issued materially misleading business information to the investing public Rosen Law Firm Securities Class Action Investor Rights Inspired Entertainment Accounting Errors
PRESS RELEASE published on 01/28/2024 at 16:34, 9 months 24 days ago EXFY DEADLINE TOMORROW: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Expensify, Inc. Investors to Secure Counsel Before Important January 29 Deadline in Securities Class Action - EXFY Rosen Law Firm alerts Expensify, Inc. investors to January 29 lead plaintiff deadline. Lawsuit alleges negligence in IPO Offering Documents and false statements about business prospects Rosen Law Firm Securities Class Action Expensify Inc. IPO Offering Documents Negligence Lawsuit
PRESS RELEASE published on 01/28/2024 at 15:35, 9 months 24 days ago ROSEN, LEADING INVESTOR COUNSEL, Encourages Evolution AB (publ) Investors to Secure Counsel Before Important Deadline in Securities Class Action - EVVTY Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of American Depositary Shares of Evolution AB (publ) between February 14, 2019 and October 25, 2023. Investors may seek compensation without out of pocket fees. To join the class action, visit https://rosenlegal.com/submit-form/?case_id=22119 or contact Phillip Kim, Esq. at 866-767-3653 or pkim@rosenlegal.com Rosen Law Firm Securities Class Action Investor Rights Class Action Lawsuit Evolution AB
PRESS RELEASE published on 01/28/2024 at 15:04, 9 months 24 days ago ROSEN, SKILLED INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR Rosen Law Firm files class action lawsuit on behalf of AlloVir, Inc. investors. Lawsuit alleges false statements regarding posoleucel Phase 3 Studies. Investors urged to secure counsel before March 19, 2024 deadline Rosen Law Firm Investor Rights Securities Litigation Class Action Lawsuit AlloVir Inc.
PRESS RELEASE published on 01/28/2024 at 15:04, 9 months 24 days ago ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX Rosen Law Firm reminds BioNTech SE investors of the lead plaintiff deadline in securities class action. Investors may be entitled to compensation Rosen Law Firm BioNTech SE Securities Class Action Lead Plaintiff Deadline Investor Compensation
PRESS RELEASE published on 01/28/2024 at 14:37, 9 months 24 days ago ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Future FinTech Group Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - FTFT Rosen Law Firm encourages Future FinTech Group Inc. investors with losses to secure counsel before the important deadline in securities class action first filed by the firm. Investors may be entitled to compensation. The firm has a track record of success in leadership roles and represents investors globally Investors Rosen Law Firm Securities Class Action Future FinTech Group Inc. Class Plaintiff Deadline
PRESS RELEASE published on 01/28/2024 at 02:03, 9 months 25 days ago GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX Rosen Law Firm encourages BioNTech SE investors to secure counsel before important deadline in securities class action. Investors may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement Investors Rosen Law Firm BioNTech SE Securities Class Action Compensation
Published on 11/22/2024 at 00:00, 4 hours 16 minutes ago Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 6 hours 11 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 6 hours 26 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 8 hours 1 minute ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 8 hours 6 minutes ago For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 19:01, 9 hours 15 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 9 hours 40 minutes ago Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 10 hours 18 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 10 hours 25 minutes ago LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 10 hours 25 minutes ago LIGHTON annonce le vif succès de son introduction en Bourse sur Euronext Growth Paris.
Published on 11/21/2024 at 06:58, 21 hours 18 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 21 hours 18 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 21 hours 18 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day 8 hours ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 8 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting